Exclusive: Mace to programme manage construction of pharmaceutical giant鈥檚 manufacturing facility in Cumbria

Mace has won the role of project manager for a 拢350m pharmaceutical manufacturing facility in Ulverston, Cumbria for pharmaceutical giant GlaxoSmithKline, 黑洞社区 has learned.

The facility, which is on the same site as one of GSK鈥檚 current manufacturing facilities, will make biopharmaceutical products.

The factory is part of a 拢500m investment programme from GlaxoSmithKline (GSK) in its operations in the UK.

The investment was trumpeted by prime minister David Cameron, when it was first announced in March this year. He said: 鈥淭his is excellent news, a major investment that will create many highly skilled jobs and provide a great boost to the economy鈥 We have a world class life sciences industry, and I am determined not just to keep it here in the UK but significantly increase it too.鈥

GSK is also considering further investment in its Ulverston plant, which could see it spend an additional 拢350m on the site.

Plus, it is already investing a further 拢100m in its two manufacturing facilities in Scotland.